RE: RE: This Week22 Sep 2025 20:06
As AS has mentioned NHS before…and is ultra conservative when it comes to comms…I think it’s a fair assumption that they have awareness of Cizzle. However, wheels turn very slowly and they also have trials of other tests so difficult to know if Ciz could realistically fit into their plans.
We know the UK is dire in terms of cancer survival relative to peers.
“Out of 33 countries of comparable wealth and income levels, the UK ranks as low as 28th for five-year survival of both stomach and lung cancer, 26th for pancreatic cancer, 25th for brain cancer and 21st and 16th for liver and oesophageal cancers respectively”
This piece below comes from the government’s own cancer plan development…due to launch a new 10 yr cancer plan this autumn…
Early diagnosis
“If cancer cannot be prevented, early diagnosis is the best tool to beat it. Cancers diagnosed in earlier stages (stages 1 and 2) can be treated more effectively and generally have higher survival rates than cancers diagnosed at later stages. Access to diagnostics will be improved by the ongoing shift from hospital to community, through community diagnostic centres and at-home testing.
Methods to improve early diagnosis can include:
* modernising cancer screening and increasing uptake
* improving awareness of cancer symptoms, removing barriers to seeking help and encouraging people to seek help quickly
* developing targeted interventions including case finding to identify patients most at risk of certain cancers
* piloting and using innovative diagnostic technologies
Early diagnosis remains critical for improving survival and is a priority for the NHS. Record improvements to early diagnosis have been led by the NHS’s early diagnosis programme. This includes the roll-out of the lung cancer screening programme (previously called targeted lung health checks), which has diagnosed more than 5,000 lung cancers, three-quarters of which are at an early stage”
Beyond the screening piece, they have the Galleri trial which is multi-cancer and limited in early diagnosis but far reaching as a trial… “using the Galleri test alongside existing cancer screening can help to find cancer early. Over 140,000 volunteers aged 50–77 have registered to take part in the trial after receiving an invitation letter from the NHS. Participants have been invited to attend three appointments over two years, about 12 months apart”
Its sensitivity for stage 1 lung cancer is just 22%, and was only c 50% for Stage 2, so Ciz at 95% - albeit lung cancer specific - is on another level.
Sign In
Follow the stocks
